Access Ov Monitor Assay
FDA 510(k) K031297 · Beckman Coulter, Inc.
510(k) numberK031297
Submission
- Device name
- Access Ov Monitor Assay
- Applicant
- Beckman Coulter, Inc.
Chaska, MN, US - Received
- April 24, 2003
- Decision date
- May 2, 2003
- Decision
- Substantially Equivalent (SESE)
- Type
- Special 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- LTK – Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.6010
- Specialty
- Immunology
Other 510(k)s with product code LTK
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K240479 | Access OV MonitorLTK · Traditional | Beckman Coulter, Inc. | 05/10/2024SE |
| K213510 | Immulite/Immulite 1000 Om-Ma, Immulite 2000 Om-MaLTK · Traditional | Siemens Healthcare Diagnostics Products, Ltd. | 09/08/2023SE |
| K221355 | VITROS Immuodiagnostic Products CA 125 II Reagent PackLTK · Traditional | Ortho Clinical Diagnostics | 12/12/2022SE |
| K200199 | ADVIA Centaur CA 125IILTK · Traditional | Siemens Healthcare Diagnostics, Inc. | 04/06/2020SE |
| K143534 | Elecsys CA-125 II assayLTK · Traditional | Roche Professional Diagnostics | 08/06/2015SE |
| K142895 | LUMIPULSE G1200 System, LUMIPULSE G CA 125II Immunoreaction Cartridges, LUMIPULSE G CA…LTK · Traditional | Fujirebio Diagnostics,Inc. | 05/21/2015SE |
| K100321 | Dimension Vista Loci Ca 125 Flex Reagent Cartridge,And Dimensions Vista Loci 6 Cal…LTK · Traditional | Siemens Healthcare Diagnostics | 04/12/2011SE |
| K080469 | Vidas Ca 15-3 AssayLTK · Traditional | bioMerieux, Inc. | 06/22/2009SE |
| K080561 | Vidas Ca 125 II AssayLTK · Traditional | bioMerieux, Inc. | 04/10/2009SE |
| K072794 | Immulite 2500 Om-Ma, Model L5KOPLTK · Special | Siemens Medical Solutions Diagnostics | 11/05/2007SE |
More from Siemens Medical Solutions Diagnostics
| 510(k) | Device | Decision |
|---|---|---|
| K252169 | Access BNP IINBC · Traditional | 03/24/2026SE |
| K254059 | Access anti-HBc IgMSEI · Traditional | 03/13/2026SE |
| K253687 | Access anti-HBc TotalSEI · Traditional | 02/19/2026SE |
| K251995 | Access anti-HAV IgMLOL · Traditional | 01/27/2026SE |
| K250588 | Access Rubella IgGLFX · Traditional | 11/17/2025SE |
| K252580 | iQ200 SeriesLKM · Special | 09/10/2025SE |
| K243846 | Access anti-HAVLOL · Traditional | 09/09/2025SE |
| K243804 | MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL)…LTT · Traditional | 08/20/2025SE |
| K250036 | MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL)LTT · Traditional | 08/15/2025SE |
| K243483 | Access hsTnIMMI · Traditional | 08/01/2025SE |
Questions and answers
When was Access Ov Monitor Assay cleared by the FDA?
Access Ov Monitor Assay (K031297) received a 510(k) decision of Substantially Equivalent on May 2, 2003, 8 days after the submission was received.
What is the product code of K031297?
The FDA product code is LTK – Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125), a Class II (moderate risk) device regulated under 21 CFR 866.6010.